Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classifica tra le azioni #26702
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prezzo delle azioni
$0.12164306
Ultima sincronizzazione: 2024-11-11
Capitalizzazione di mercato
$38.53M
Variazione (1 giorno)
-4.14%
Variazione (1 anno)
0.00%
Paese
AU
Scambia PharmAust Limited (PAA)

Categoria

Cronologia dei frazionamenti azionari per PharmAust Limited (PAA)
L’azione PharmAust Limited (simbolo: PAA) ha subito un totale di 4 frazionamenti.
L’ultimo frazionamento è avvenuto il Feb 20, 2019.
Una quota di PAA acquistata prima di Nov 15, 2004 equivale oggi a 0.011443846153846 quote di PAA.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2019-02-20 551:500 x1.102 x0.011443846153846
2016-11-10 27:26 x1.0384615384615 x0.010384615384615
2015-10-30 1:20 x0.05 x0.01
2004-11-15 1:5 x0.2 x0.2
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US